- Home
- HNST vs SANA Comparison
HNST vs SANA Comparison
Compare HNST & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNST
- SANA
- Stock Information
- Founded
- HNST 2012
- SANA 2018
- Country
- HNST United States
- SANA United States
- Employees
- HNST N/A
- SANA N/A
- Industry
- HNST Catalog/Specialty Distribution
- SANA Medicinal Chemicals and Botanical Products
- Sector
- HNST Consumer Discretionary
- SANA Health Care
- Exchange
- HNST Nasdaq
- SANA Nasdaq
- Market Cap
- HNST 481.4M
- SANA 519.8M
- IPO Year
- HNST 2021
- SANA 2021
- Fundamental
- Price
- HNST $4.39
- SANA $1.65
- Analyst Decision
- HNST Buy
- SANA Strong Buy
- Analyst Count
- HNST 4
- SANA 5
- Target Price
- HNST $7.63
- SANA $9.50
- AVG Volume (30 Days)
- HNST 2.5M
- SANA 4.4M
- Earning Date
- HNST 05-07-2025
- SANA 05-07-2025
- Dividend Yield
- HNST N/A
- SANA N/A
- EPS Growth
- HNST N/A
- SANA N/A
- EPS
- HNST N/A
- SANA N/A
- Revenue
- HNST $378,340,000.00
- SANA N/A
- Revenue This Year
- HNST $7.26
- SANA N/A
- Revenue Next Year
- HNST $4.84
- SANA N/A
- P/E Ratio
- HNST N/A
- SANA N/A
- Revenue Growth
- HNST 9.87
- SANA N/A
- 52 Week Low
- HNST $2.40
- SANA $1.26
- 52 Week High
- HNST $8.97
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- HNST 40.54
- SANA 42.97
- Support Level
- HNST $4.29
- SANA $1.53
- Resistance Level
- HNST $4.55
- SANA $1.92
- Average True Range (ATR)
- HNST 0.31
- SANA 0.22
- MACD
- HNST 0.02
- SANA 0.05
- Stochastic Oscillator
- HNST 46.56
- SANA 59.09
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.